2.Visual analysis of articles on alarm management of clinical medical equipment based on CiteSpace
Chao WU ; Ya-Wei LIN ; Wei-Yun YUAN ; Yan-Ling DU ; Shi-Zhe HE ; Hong-Juan LANG
Chinese Medical Equipment Journal 2023;44(12):63-68
The articles on alarm management of clinical medical equipment from January 2000 to January 2023 were collected with common databases in the world as search sources.CiteSpace software was used for trend drawing of annual publication distribution,author cooperation network mapping,country/institution cooperation network mapping and keyword knowledge mapping,and for analyzing related issues in depth.The annual publication of medical equipment alarm management research showed a fluctuating upward trend,the authors had good cooperative relationship with the organizations,the hotspots included ventilator,alarm and alarm fatigue in Chinese and alarm fatigue,intensive care unit and patient safety in English,and the research frontier involved in alarm fatigue,false alarm and alarm management.References were provided for conducting related research in China.
3.Impact of hepatitis B virus infection on liver function after hematopoietic stem cell transplantation.
Dong-Ping WANG ; Jun WANG ; Guang-Wen LI ; Zong-Ke GAO ; Zeng-Qiang ZHAO ; Zheng LIANG ; Chao-Lang WEI ; Bo-Long ZHANG
Journal of Experimental Hematology 2013;21(1):173-176
To analyze the impact of hepatitis B virus (HBV) infection on liver function of patients after hematopoietic stem cell transplantation (HSCT), the transplantation outcome of 48 patients infected with HBV prior to transplantation among 185 patients received HSCT was investigated retrospectively. The results showed that during a follow-up for 6 months after HSCT, the alanine aminotransferase (ALT) peak average values of the patients with HBsAg(+), HBsAb(+) and control groups were (281.6 ± 414.6), (95.4 ± 79.9) and (65.1 ± 44.2) U/L, respectively. The incidences of abnormal liver function of the patients with HBsAg(+), HBsAb(+) and control groups were 61.54%, 40.00% and 30.23% respectively. There were no significant differences between any two groups (P > 0.05). The lethality of those patients at late period after transplantation was not related to HBV infection. The hepatocirrhosis and hepatocarcinoma caused by HBV infection have not become major problems in long-term survivors. It is concluded that in HBsAg(+) patients received HSCT, the damage of liver function is more severe than control group, possibly increasing the development of abnormal liver function. The measures against the liver function damage should be taken. The prophylactic administration of ganciclovir for virus may be effective to prevent the activation of HBV.
Adolescent
;
Adult
;
Child
;
Female
;
Hematopoietic Stem Cell Transplantation
;
adverse effects
;
Hepatic Veno-Occlusive Disease
;
etiology
;
prevention & control
;
Hepatitis B
;
physiopathology
;
Hepatitis B virus
;
Humans
;
Liver
;
physiopathology
;
virology
;
Liver Function Tests
;
Male
;
Middle Aged
;
Retrospective Studies
;
Young Adult
4.Clinical efficacy of Kanggu Zengsheng capsule on treatment of knee-osteoarthritis
Kai ZHOU ; Lei CHEN ; Jun-Zhe LANG ; Jing LI ; Cheng-Wei CHEN ; Chao ZHANG ; Kai CHEN
The Chinese Journal of Clinical Pharmacology 2015;(13):1249-1251,1261
Objective To evaluate the clinical effect of Kanggu Zengsheng capsule on treatment of knee -osteoarthritis and its effect on anti -inflammation and anti -oxidation. Methods One hundred patients with knee-osteoarthritic were randomly divided into two groups . Patients in the treatment group ( n=50 ) were orally administrated with 3 Kanggu Zengsheng capsules each time , tid, and those in the control group (n=50) were given diacerein (50 mg bid, po) and celecoxib (200 mg qd, po) for four weeks.The data of Visual Analogue Scale ( VAS ) , Womac score , Lequesne index and interleukin 1 beta ( IL-1β) , tumor necrosis factor alpha ( TNF-α) , matrix metallopro-teinases-3 ( MMP-3 ) , hyaluronic acid ( HA ) , nitric oxide ( NO ) , nitric oxide synthase ( iNOS ) , lipid peroxide ( LPD ) and superoxide dismutase ( SOD ) in serum and synovia were observed in two groups . Results After treatment , the data of VAS score , Womac score , Lequesne index in two groups were significantly improved , and the abilities to inhibit IL-1β, TNF-α, MMP-3 , NO, iNOS and LPD in treatment group were better than the control group .The treatment group also displayed a better capability in increasing SOD compared with the control group. Conclusion Kanggu Zengsheng capsule has a better efficacy on knee -OA than traditional treatment methods ( diacereinand plus celecoxib ).
5.Effect of diet on the pharmacokinetic of Picika oral solution in healthy human
Feng DUAN ; Zhen-Zhen ZHU ; Jing-Feng BI ; Ben-Chao CHEN ; Zhen CHEN ; Li ZHANG ; Hui JI ; Li-Wei LANG ; Min WANG ; Zhen-Man WEI
The Chinese Journal of Clinical Pharmacology 2016;(3):227-229
Objective To study the influence of diet on the pharmacoki-netic of Picika oral solution in healthy subjects.Methods This study taken random , before and after self-control design.Twelve subjects were randomly divided into 2 groups, each group was 6 cases, then they were given Picika oral solution 60 mL respectively before and after meal.Before and after administration , blood and urine samples were collected at different points , the plasma and urine concentration was measured and pharmacokinetic parameters were calculated.Results Before and after administration of Picika oral solution 60 mL, the drug pharmacokinetic parameters of active ingredients -CKL-A03 were listed as follows:t1/2 was ( 126.13 ± 74.04 ) , ( 104.81 ± 68.44 ) min; tmax were (53.75 ±10.03 ) and (58.75 ±11.89 ) min;Cmax were (3.06 ±0.86 ) and ( 3.81 ±2.82 )μg· L-1; AUC0-t were ( 268.81 ±84.25 ) and (355.03 ±177.82 )μg· L-1 · min in plasma respectively.t1/2 was (1.14 ± 0.12 ), ( 1.24 ± 0.16 ) h in the urine respectively.Conclusion Diet may affect the absorption and eliminate speed of the drug.
6.Pharmacokinetics of single dose of Picika oral solution in Chinese healthy volunteers
Zhen-Zhen ZHU ; Feng DUAN ; Jing-Feng BI ; Zhen CHEN ; Min WANG ; Li ZHANG ; Hui JI ; Li-Wei LANG ; Ben-Chao CHEN ; Zhen-Man WEI
The Chinese Journal of Clinical Pharmacology 2016;(3):230-234
Objective To evaluate the pharmacokinetic changes of Picika oral solution in healthy subjects after single dose.Methods This study taken random , three cross experiment design , 12 subjects were randomly divided into 6 groups, each group was 2 cases, then they were respec-tively given single oral doseof Picika oral solution (60, 90, 120 mL) in each cycle.Before and after administration , biological samples were col-lected for detection of blood drug concentration and urine drug concentra-tion, furthermore, calculation of blood and urine drug pharmacokinetic parameters.Results After single oral dose of 60, 90, 120 mL Picika oral solution, the main pharmacokinetic parameters of plasma CKL -A03, Cmax were (3.08 ±0.92), (3.63 ±0.75), (4.29 ±1.00)μg· L-1, tmax were (57.50 ±17.90 ), (52.50 ±20.73 ), (56.25 ±19.32 ) min, t1/2 were (197.51 ±106.35 ), (233.86 ±196.75 ), (141.34 ±65.16 ) min, AUC0-t were ( 383.28 ± 86.42 ) , ( 479.00 ± 136.25 ) , (540.59 ±102.87)μg · L-1 · min, AUC0-∞ were (710.06 ±233.03 ), (916.59 ±378.62 ), (782.65 ±130.40 )μg· L-1 · min, respectively. The main pharmacokinetic parameters of urine CKL -A03, t1/2 were (1.29 ±0.33), (1.23 ±0.20), (1.11 ±0.11) h, total urine discharge rates were (0.28 ±0.22)%, (0.20 ±0.11)%, (0.18 ±0.09)%, urine discharge amount were (74486.02 ±57923.42 ), (80015.14 ±43379.01 ), (93017.33 ±46658.61 ) mg.Conclusion The maximum oral absorption amount of Picika oral solution is possible 90 mL.And there is no apparent proportional relationship between the total urine discharge rate , urine discharge amount and the increased doses.
8.Biomechanical advantages of medial support screws in locking plate for treating proximal humerus fractures
Lang-qing ZENG ; Yun-feng CHEN ; Yuan-chao LI ; Lei WANG ; Wen-qi SONG ; Yan-jie LIU ; Wei ZHANG ; Chang-qing ZHANG ; Bing-fang ZENG
Journal of Medical Biomechanics 2013;28(3):E338-E343
Objective To evaluate the biomechanical advantages of medial support screws (MSSs) in locking proximal humeral plate for treating proximal humerus fractures. Methods Thirty synthetic left humeri were randomly divided into 3 groups to establish the fracture models. Group A was fixed with a locking proximal humerus plate with medial cortical support, but without MSSs; group B was fixed with 3 MSSs, but without medial cortical support; group C was fixed with neither medial cortical support nor MSSs. Axial compression, torsion, shear stiffness and failure tests were applied on the specimens of the three groups. Results For axial compression tests, the maximum load of group A, B, C was (240.88±19.13), (169.04±19.26), (128.58±17.53) N, respectively; the axial stiffness of group A, B, C was (424.4±101.2), (230.7±40.54), (147.0±29.2) N/mm, respectively, showing significant differences (P<0.05). For torsion tests, the maximum torque of group C was (7.57±0.53) N•m, which was statistically different from both group A((8.92±0.25) N•m) and group B((9.09±0.31) N•m, P<0.05), and the torsional stiffness of group C((1.53±0.10) N•m/(°)) was statistically different from both group A((1.80±0.07) N•m/(°)) and group B((1.86±0.07) N•m/(°), P<0.05), but no significant differences were found between groups A and groups B in the maximum torque and torsional stiffness(P>0.05). For shear stiffness tests, the maximum load of group A, B, C was (444.71±20.87), (228.79±28.95), (188.73±26.15) N, respectively; the shear stiffness of group A, B, C was (70.0± 54.4), (183.89±29.64), (140.2±32.1) N/mm, respectively, showing significant differences (P<0.05). For failure tests, the failure load of group A ((2 949.76±355.08) N) was statistically different from both group B ((2 448.13±402.39)N) and group C ((2 222.55±336.41) N) (P<0.05), but no statistical differences were found between group B and group C (P>0.05). Conclusions Using three MSSs in locking plate for proximal humerus fractures shows optimal biomechanical properties, as compared to the situation without restoration of the medial column support. The reconstruction of the medial cortical support or MSSs for proximal humerus fractures helps to enhance the mechanical stability of the humeral head and prevent failure after internal fixation.
9.Mortality and Morbidity of Extremely Low Birth Weight Infants in the Mainland of China: A Multi-center Study.
Hui-Jia LIN ; Li-Zhong DU ; Xiao-Lu MA ; Li-Ping SHI ; Jia-Hua PAN ; Xiao-Mei TONG ; Qiu-Ping LI ; Jian-Guo ZHOU ; Bing YI ; Ling LIU ; Yun-Bing CHEN ; Qiu-Fen WEI ; Hui-Qing WU ; Mei LI ; Cui-Qing LIU ; Xi-Rong GAO ; Shi-Wen XIA ; Wen-Bin LI ; Chao-Ying YAN ; Ling HE ; Kun LIANG ; Xiao-Yu ZHOU ; Shu-Ping HAN ; Qin LYU ; Yin-Ping QIU ; Wen LI ; Dong-Mei CHEN ; Hong-Ru LU ; Xiao-Hong LIU ; Hong LIU ; Zhen-Lang LIN ; Li LIU ; Jia-Jun ZHU ; Hong XIONG ; Shao-Jie YUE ; Si-Qi ZHUANG
Chinese Medical Journal 2015;128(20):2743-2750
BACKGROUNDWith the progress of perinatal medicine and neonatal technology, more and more extremely low birth weight (ELBW) survived all over the world. This study was designed to investigate the short-term outcomes of ELBW infants during their Neonatal Intensive Care Unit (NICU) stay in the mainland of China.
METHODSAll infants admitted to 26 NICUs with a birth weight (BW) < l000 g were included between January l, 2011 and December 31, 2011. All the data were collected retrospectively from clinical records by a prospectively designed questionnaire. The data collected from each NICU transmitted to the main institution where the results were aggregated and analyzed. Categorical variables were performed with Pearson Chi-square test. Binary Logistic regression analysis was used to detect risk factors.
RESULTSA total of 258 ELBW infants were admitted to 26 NICUs, of whom the mean gestational age (GA) was 28.1 ± 2.2 weeks, and the mean BW was 868 ± 97 g. The overall survival rate at discharge was 50.0%. Despite aggressive treatment 60 infants (23.3%) died and another 69 infants (26.7%) died after medical care withdrawal. Furthermore, the survival rate was significantly higher in coastal areas than inland areas (53.6% vs. 35.3%, P = 0.019). BW < 750 g and GA < 28 weeks were the largest risk factors, and being small for gestational age was a protective factor related to mortality. Respiratory distress syndrome was the most common complication. The incidence of patent ductus arteriosus, intraventricular hemorrhage, periventricular leukomalacia, bronchopulmonary dysplasia, retinopathy of prematurity was 26.2%, 33.7%, 6.7%, 48.1%, and 41.4%, respectively. Ventilator associated pneumonia was the most common hospital acquired infection during hospitalization.
CONCLUSIONSOur study was the first survey that revealed the present status of ELBW infants in the mainland of China. The mortality and morbidity of ELBW infants remained high as compared to other developed countries.
China ; Female ; Humans ; Infant ; Infant Mortality ; Infant, Extremely Low Birth Weight ; Infant, Newborn ; Intensive Care Units, Neonatal ; statistics & numerical data ; Male ; Morbidity ; Respiratory Distress Syndrome, Newborn ; mortality ; Retrospective Studies ; Surveys and Questionnaires
10.Consensus for the management of severe acute respiratory syndrome.
Nanshang ZHONG ; Yanqing DING ; Yuanli MAO ; Qian WANG ; Guangfa WANG ; Dewen WANG ; Yulong CONG ; Qun LI ; Youning LIU ; Li RUAN ; Baoyuan CHEN ; Xiangke DU ; Yonghong YANG ; Zheng ZHANG ; Xuezhe ZHANG ; Jiangtao LIN ; Jie ZHENG ; Qingyu ZHU ; Daxin NI ; Xiuming XI ; Guang ZENG ; Daqing MA ; Chen WANG ; Wei WANG ; Beining WANG ; Jianwei WANG ; Dawei LIU ; Xingwang LI ; Xiaoqing LIU ; Jie CHEN ; Rongchang CHEN ; Fuyuan MIN ; Peiying YANG ; Yuanchun ZHANG ; Huiming LUO ; Zhenwei LANG ; Yonghua HU ; Anping NI ; Wuchun CAO ; Jie LEI ; Shuchen WANG ; Yuguang WANG ; Xioalin TONG ; Weisheng LIU ; Min ZHU ; Yunling ZHANG ; Zhongde ZHANG ; Xiaomei ZHANG ; Xuihui LI ; Wei CHEN ; Xuihua XHEN ; Lin LIN ; Yunjian LUO ; Jiaxi ZHONG ; Weilang WENG ; Shengquan PENG ; Zhiheng PAN ; Yongyan WANG ; Rongbing WANG ; Junling ZUO ; Baoyan LIU ; Ning ZHANG ; Junping ZHANG ; Binghou ZHANG ; Zengying ZHANG ; Weidong WANG ; Lixin CHEN ; Pingan ZHOU ; Yi LUO ; Liangduo JIANG ; Enxiang CHAO ; Liping GUO ; Xuechun TAN ; Junhui PAN ; null ; null
Chinese Medical Journal 2003;116(11):1603-1635